logo
logo

Wavely Diagnostics Announces New Funding To Accelerate Commercial Launch, Scale Delivery Of Only Digital Diagnostics Platform For Childhood Ear Infections

Jul 12, 2023•about 2 years ago
SeattleConsumer GoodsHealth Care

Description

Wavely Diagnostics, Inc., a digital diagnostics company developing smartphone-based apps to bring accurate, data-driven virtual pediatric care into every U.S. household, raised $1.35MM in new funding to advance its first-of-its-kind digital diagnostics platform for enabling virtual ear infection care for children, bringing Wavely’s total investor and grant funding to $6.35MM. The new funding will enable Wavely to seize upon growing interest from healthcare systems and pediatric care providers and accelerate development ahead of its planned public release in app stores later this year. Robin Hood Ventures is leading the funding round with follow-on investment from WRF Capital, Ambit Health Ventures, the WXR Fund, Wealthing, HealthTech Capital, and Princeton Alumni Angels.

Company Information

Company

Wavely Diagnostics

Location

2311 N 45TH STREET #207

Seattle, Washington, United States

About

Wavely Diagnostics is enabling pediatric virtual care through its platform of app-based diagnostic solutions that provide the key physical exam findings for the most common reasons for pediatric visits. Beginning with ear infections, the platform will eventually offer diagnostics to enable nearly 70% of acute pediatric visits to shift virtual. By leveraging smartphone technology with no additional training or hardware requirements, Wavely significantly increases access to high-quality, patient-centric care, at any time, from anywhere. Currently available to healthcare systems for pilots, the app will launch broadly in late 2023. Founded as an academic spinout of University of Washington in 2018, the Seattle-based company rebranded as Wavely Diagnostics and received its first venture investment in 2021.

Related People